Kim B J BJ - OmicsDI

Show results for

Unknown (668)
Proteomics (23)
Genomics (21)
Transcriptomics (13)
Metabolomics (8)

Organisms

Homo sapiens (42)
Drosophila melanogaster (4)
Mus musculus (3)
Yarrowia lipolytica (2)
Agrobacterium tumefaciens (1)
Staphylococcus aureus (1)
Betaherpesvirinae (1)
Chlorocebus aethiops (1)
Human herpesvirus 5 strain Merlin (1)
Macaca mulatta (1)

Repository

EGA (20)
pride (20)
biostudies-arrayexpress (14)
MetaboLights (8)
MassIVE (3)

Tissue

Epithelial cell (8)
Cell culture (5)
B cell (2)
B-cell chronic lymphocytic leukemia cell (2)
Breast (2)
Monocyte (2)
Blood plasma (1)
Blood serum (1)
Breast cancer cell (1)
Cerebrospinal fluid (1)
Epithelium of pancreatic duct (1)
Fibroblast (1)
HeLa cell (1)
Kidney (1)
Lung (1)
Malignant cell (1)
PanIN cell (1)
Pancreatic duct (1)
Pancreatic ductal adenocarcinoma cell (1)
Permanent cell line cell (1)
Primary cell (1)

Disease

Avian influenza (3)
Breast cancer (3)
Influenza (3)
Chronic lymphocytic leukemia (2)
Cervix carcinoma (1)
Disease free (1)
Iron deficiency anemia (1)
Pancreatic ductal adenocarcinoma (1)

Technology Type

Mass Spectrometry (20)
Shotgun proteomics (12)
Mass spectrometry (7)
Affinity purification coupled with mass spectrometry proteomics (4)
Bottom-up proteomics (3)
SRM/MRM (2)
NMR spectroscopy (1)
Data-dependent acquisition (1)
SWATH MS (1)

Instrument Platform

5975C Series GC/MSD (Agilent) (3)
RiboZero (2)
Trizol (Invitrogen); FastPrep (MP Biochemicals) (2)
DASGIP bioreactors (2)
Ion Torrent Proton (2)
Liquid Chromatography MS - negative - hilic (2)
Liquid Chromatography MS - positive - hilic (2)
Illumina HiSeq 2000 (1)
Exactive Plus (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion Lumos (1)
LTQ Orbitrap Velos (Thermo Scientific) (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
MS Imaging - (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2022 (6)
2020 (5)
2024 (5)
2013 (4)
2023 (4)
2014 (3)
2011 (3)
2018 (3)
2017 (2)
2016 (2)
2026 (2)
2021 (1)
2015 (1)
2012 (1)
2010 (1)
2025 (1)
2019 (1)

CHEBI ID

CHEBI:15971 (4)
CHEBI:16015 (4)
CHEBI:16737 (4)
CHEBI:17368 (4)
CHEBI:15354 (3)
CHEBI:15428 (3)
CHEBI:15741 (3)
CHEBI:15891 (3)
CHEBI:16027 (3)
CHEBI:16199 (3)
CHEBI:16411 (3)
CHEBI:16414 (3)
CHEBI:16857 (3)
CHEBI:16919 (3)
CHEBI:16977 (3)
CHEBI:17191 (3)
CHEBI:17268 (3)
CHEBI:17568 (3)
CHEBI:17724 (3)
CHEBI:17754 (3)
CHEBI:17895 (3)
CHEBI:18019 (3)
CHEBI:18132 (3)
CHEBI:30769 (3)
CHEBI:32816 (3)
CHEBI:73024 (3)
CHEBI:7916 (3)
CHEBI:14314 (2)
CHEBI:15318 (2)
CHEBI:15584 (2)

Metabolite Name

Choline (3)
Creatine (3)
Creatinine (3)
Taurine (3)
2-Methylbutyroylcarnitine (2)
Acetylcarnitine (2)
Alanine (2)
Betaine (2)
D-malic acid (2)
Decanoyl-L-carnitine (2)
Dimethylglycine (2)
Guanosine (2)
Hypoxanthine (2)
Isoleucine (2)
L-Arginine (2)
L-Glutamate (2)
L-Histidine (2)
L-alanine (2)
L-cysteine (2)
L-glutamic acid (2)
L-histidine (2)
L-lysine (2)
L-serine (2)
L-threonine (2)
N-Acetyl-L-alanine (2)
N2-Acetyl-L-ornithine (2)
Trigonelline (2)
Trimethylamine N-oxide (2)
Uridine (2)
Xanthine (2)

Study type

Transcription profiling by array (8)
RNA-seq of coding RNA (3)
RIP-seq (1)
ChIP-seq (1)
RNA-seq of non coding RNA (1)

Release Date

2021 (84)
2023 (75)
2020 (75)
2022 (68)
2024 (59)
2025 (46)
2015 (38)
2016 (32)
2018 (29)
2013 (28)
2019 (28)
2017 (27)
2014 (26)
2026 (21)
2011 (18)
2012 (11)
2010 (7)
2009 (4)
2008 (2)
2007 (2)
2003 (1)
2001 (1)

Lab affiliation

Baylor College of Medicine (2)
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, 75390, TX, USA (2)
1Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA (1)
Asan Medical Center, Clinical Proteomics Core, Republic of Korea (1)
Cambridge Institute for Medical Research, University of Cambridge, CB2 0XY, UK (1)
Department of Cellular and Molecular Pharmacology, University of California San Francisco, USA (1)
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Korea (1)
Department of Oncology-Pathology, Karolinska Institutet and Science for Life Laboratory (1)
Dept. Cellular Molecular Pharmacology, University of California - San Francisco (UCSF), USA (1)
Dept. Cellular Molecular Pharmacology, University of San Francisco (UCSF), USA (1)
Dept. Cellular and Molecular Pharmacology, University of California - San Francisco (UCSF), USA (1)
Director, Division of Neonatology Department of Pediatrics Center for Neurobehavioral Development University of Minnesota (1)
Experimental Radiation Oncology, The University of Texas, MD Anderson Cancer Center (1)
Institute for Systems Biology (1)
OmicVision Biosciences ApS (1)
QBI director and professor, Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA 94158, USA. Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158, USA (1)
Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden (1)
UCSF (1)

Previous page
1 / 74
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 74
Next page

Sort by:

Relevance

Page size

Multiomic profiling of iron-deficient infant monkeys reveals alterations in neurologically important biochemicals in serum and cerebrospinal fluid before the onset of anemia

The effects of iron deficiency (ID) during infancy extend beyond the hematologic compartment and include short- and long-term adverse effects on many tissues including the brain. However, sensitive biomarkers of iron-dependent brain health are lacking in humans. To determine whether serum and cer...

2022-07-12 | MTBLS3388 | MetaboLights

Proteogenomic subtyping of chronic lymphocytic leukemia identifies subgroups with contrasting clinical outcome and distinct ex-vivo drug response profile

We have performed a comprehensive proteomic analysis of clinical patient samples of chronic lymphocytic leukemia (CLL) alongside genome-, transcriptome- and ex-vivo drug response profiling. Trisomy 12 and IGHV mutation status had the strongest impact on the proteome and transcriptome; and SF3B1 muta...

ORGANISM(S): Homo sapiens (Human)

2024-06-21 | PXD017453 | Pride

Proteogenomic subtyping of chronic lymphocytic leukemia identifies subgroups with contrasting clinical outcome and distinct ex-vivo drug response profile

ORGANISM(S): Homo sapiens (Human)

2022-10-17 | PXD028936 | Pride

Lymphoblast B-cell Chronic lymphoblastic leukemia Proteogenomics Human Lc-ms Leukemia Cancer Clinical samples. Hirief Proteomics

Differentiation of mycobacterial species by PCR-restriction analysis of DNA (342 base pairs) of the RNA polymerase gene (rpoB).

Not available

S-EPMC88096 | biostudies-literature

Global prevalence and molecular characteristics of three clades within hepatitis B virus subgenotype C2: Predominance of the C2(3) clade in South Korea.

Not available

S-EPMC10033913 | biostudies-literature

Proteogenomic markers of chemotherapy resistance and response in triple negative breast cancer

Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, Vashist TD, Huynh AMT, Dou Y, Gou X, Huang C, Shi Z, Wen B, Korchina V, Gibbs RA, Muzny DM, Doddapaneni H, Dobrolecki LE, Rodriguez H, Robles AI, Hiltke T, Lewis MT, Nangia J, Shafaee MN, Hagemann I, Hoog J, Lim B, Osborne CK, Mani DR, Gill...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2022-06-29 | MSV000089758 | MassIVE

Identification of CDK1 phosphorylation of TFCP2L1 from murine embryonic stem cells and bladder cancer cells

Molecular programs involved in embryogenesis are frequently upregulated in oncogenic dedifferentiation and metastasis. However, their precise roles and regulatory mechanisms remain elusive. Here, we showed that CDK1 phosphorylation of TFCP2L1, a pluripotency-associated transcription factor, orches...

ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse)

2019-11-08 | PXD015635 | Pride

Pluripotency Cdk1 Stemness features Embryonic stem-cell Bladder cancer

A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine.

Not available

S-EPMC10272379 | biostudies-literature

Use of Valsalva Maneuver to Detect Late-Onset Delayed Orthostatic Hypotension.

Not available

S-EPMC10023507 | biostudies-literature

Targeting the SREBP-dependent lipidomic reprogramming by virus infection for broad-spectrum therapeutic intervention

Viruses are obligate intracellular parasites that exploit the host metabolic machineries to meet their extraordinary biosynthetic demands. Integrative transcriptomic and lipidomic profiling confirmed that Middle East respiratory syndrome coronavirus (MERS-CoV) infection reprograms the host lipid met...

2018-11-26 | MTBLS762 | MetaboLights

Previous page
1 / 74
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 74
Next page

Sort by:

Relevance

Page size

733 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets